Abstract
Purpose
Previous evidence implicates CYP1A1 and GSTM1 polymorphisms as risk factors for various cancers. A number of studies have been devoted to the association of CYP1A1 or GSTM1 polymorphism with susceptibility to laryngeal carcinoma, with the results inconsistent and inconclusive. The aim of the present study was to assess the possible associations of laryngeal cancer risk with CYP1A1 genetic variation and GSTM1 null genotype respectively.
Methods
The associated literature was acquired through deliberate searching and selected based on the established inclusion criteria for publications, then the extracted data were further analyzed using systematic meta-analyses.
Results
The results showed that the overall odds ratio (OR) was 1.32 (95% CI = 1.08–1.61) for CYP1A1 Mspl polymorphism. Using subgroup analysis, the pooled ORs were 1.38 (95% CI = 0.98–1.95) in Asians and 1.29 (95% CI = 1.01–1.65) in Caucasians. For CYP1A1 exon7 polymorphism, the overall OR was 1.38 (95% CI = 0.98–1.95). The overall OR was 1.24 (95% CI = 1.03–1.49) for GSTM1 polymorphism and the pooled ORs were 1.36 (95% CI = 0.75–2.48) in Asians, 1.16 (95% CI = 0.94–1.44) in Caucasians and 1.52 (95% CI = 1.05–2.19) in Turkey population.
Conclusions
The data suggest CPY1A1 MspI polymorphism as a risk factor for laryngeal cancer in Caucasians but not in Asians. However, the results suggest a marked correlation of GSTM1 polymorphism with laryngeal cancer risk in Turkey population but not Caucasians and Asians.
Similar content being viewed by others
Abbreviations
- CYP1A1:
-
Cytochrome P450 1A1
- GSTM1:
-
Glutathione S-transferase M1
- ORs:
-
Odds ratios
- CIs:
-
Confidence intervals
References
Acar H, Ozturk K, Muslumanoglu MH, Yildirim MS, Cora T, Cilingir O, Ozer B (2006) Relation of glutathione S-transferase genotypes (GSTM1 and GSTT1) to laryngeal squamous cell carcinoma risk. Cancer Genet Cytogenet 169(2):89–93
Bardakci F, Canbay E, Degerli N, Coban L, Canbay EI (2003) Relationship of tobacco smoking with GSTM1 gene polymorphism in laryngeal cancer. J Cell Mol Med 7(3):307–312
Bennett DA, Latham NK, Stretton C, Anderson CS (2004) Capture-recapture is a potentially useful method for assessing publication bias. J Clin Epidemiol 57(4):349–357
Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G (2006) Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis 21(2):115–123
Cabelguenne A, Loriot MA, Stucker I, Blons H, Koum-Besson E, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P, De Waziers I (2001) Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer 93(5):725–730
Coutelle C, Ward PJ, Fleury B, Quattrocchi P, Chambrin H, Iron A, Couzigou P, Cassaigne A (1997) Laryngeal and oropharyngeal cancer, and alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet 99(3):319–325
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574(1–2):112–123
Gronau S, Koenig-Greger D, Jerg M, Riechelmann H (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol Head Neck Surg 128(5):674–680
Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Rudnai P, Brennan P (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe. Am J Epidemiol 165(7):814–820
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
Hong YJ, Lee JK, Lee GH, Hong SI (2000) Influence of glutathione S-transferase M1 and T1 genotypes on larynx cancer risk among Korean smokers. Clin Chem Lab Med 38(9):917–919
Jahnke V, Matthias C, Fryer A, Strange R (1996) Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg 172(6):671–673
Jourenkova N, Reinikainen M, Bouchardy C, Dayer P, Benhamou S, Hirvonen A (1998) Larynx cancer risk in relation to glutathione S-transferase Ml and T1genotypes and tobacco smoking. Cancer Epidemiol Biomarkers Prev 7:19–23
La Torre G, Boccia S, Ricciardi G (2005) Glutathione S-transferase M1 status and gastric cancer risk: a meta-analysis. Cancer Lett 217(1):53–60
Lai R, Crevier L, Thabane L (2005) Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumors: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14(7):1784–1790
Lau J, Ioannidis JP, Terrin N, Schmid CH, Olkin I (2006) The case of the misleading funnel plot. BMJ 333(7568):597–600
Lei D, Pan X, Guo C, Luan X, Xu F, Zhang L, Liu D (2002) Genetic polymorphism of cytochrome P4501A1 and susceptibility to laryngeal carcinoma. Zhonghua Er Bi Yan Hou Ke Za Zhi 37(5):373–376
Li L, Lin P, Deng YF, Zhu ZL, Lu HH (2004) Relationship between susceptibility and prognosis of laryngeal cancer and genetic polymorphisms in CYP1A1 and GSTM1. Zhonghua Er Bi Yan Hou Ke Za Zhi 39(1):2–7
Masson LF, Sharp L, Cotton SC, Little J (2005) Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: a HuGE review. Am J Epidemiol 161(10):901–915
Matthias C, Bockmühl U, Jahnke V, Jones PW, Hayes JD, Alldersea J, Gilford J, Bailey L, Bath J, Worrall SF, Hand P, Fryer AA, Strange RC (1998) Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics 8(2):91–100
Moon KS, Lee HJ, Hong SH, Kim HM, Um JY (2007) CYP1A1 and GSTM1/T1 genetic variation in predicting risk for cerebral infarction. J Mol Neurosci 32(2):155–159
Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, Miki H, Fujii T, Yoshino K, Kusuoka H, Monden M (1999) Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 80(5):685–688
Ntais C, Polycarpou A, Ioannidis JP (2005) Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 14(1):176–181
Peters ES, McClean MD, Marsit CJ, Luckett B, Kelsey KT (2006) Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15(11):2196–2202
Risch A, Ramroth H, Raedts V, Rajaee-Behbahani N, Schmezer P, Bartsch H, Becher H, Dietz A (2003) Laryngeal cancer risk in Caucasians is associated with alcohol and tobacco consumption but not modified by genetic polymorphisms in class I alcohol dehydrogenases ADH1B and ADH1C, and glutathione-S-transferases GSTM1 and GSTT1. Pharmacogenetics 13(4):225–230
Rosenthal R (1979) The “file drawer problem” and tolerance for null results. Psychol Bull 86:638–641
Shi X, Zhou S, Wang Z, Zhou Z, Wang Z (2008) CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: a meta-analysis. Lung Cancer 59(2):155–163
Sull JW, Ohrr H, Kang DR, Nam CM (2004) Glutathione S-transferase M1 status and breast cancer risk: a meta-analysis. Yonsei Med J 45(4):683–689
Terrin N, Schmid CH, Lau J (2005) In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 58(9):894–901
To-Figueras J, Gené M, Gómez-Catalán J, Piqué E, Borrego N, Caballero M, Cruellas F, Raya A, Dicenta M, Corbella J (2002) Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett 187(1–2):95–101
Unal M, Tamer L, Ateş NA, Akbaş Y, Pata YS, Vayisoğlu Y, Ercan B, Görür K, Atik U (2004) Glutathione S-transferase M1, T1, and P1 gene polymorphism in laryngeal squamous cell carcinoma. Am J Otolaryngol 25(5):318–322
Varzim G, Monteiro E, Silva RA, Fernandes J, Lopes C (2003) CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev 12(6):495–499
Wittke-Thompson JK, Pluzhnikov A, Cox NJ (2005) Rational inferences about departures from Hardy–Weinberg equilibrium. Am J Hum Genet 76(6):967–986
White DL, Li D, Nurgalieva Z, El-Serag HB (2008) Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol 167(4):377–389
Yang CX, Matsuo K, Wang ZM, Tajima K (2005) Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature. World J Gastroenterol 11(17):2531–2538
Acknowledgments
This work was partially supported by the postgraduate funds of Third Military Medical University (2005256), the National Natural Science Foundation of China (30800506) and Natural Science Foundation of Chongqing (CSTC, 2008BB5124). Moreover, we take this opportunity to thank the anonymous reviewers and editors for their constructive comments that may prove helpful in our future research.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
The author Xian-Lu Zhuo works at Guiyang Medical College.
Rights and permissions
About this article
Cite this article
Zhuo, WL., Wang, Y., Zhuo, XL. et al. Polymorphisms of CYP1A1 and GSTM1 and laryngeal cancer risk: evidence-based meta-analyses. J Cancer Res Clin Oncol 135, 1081–1090 (2009). https://doi.org/10.1007/s00432-009-0548-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-009-0548-x